#endtb

[image ID: the destiel confession meme. cas says "I love you.

dean replies: "the endTB clinical trial found 3 new all-oral drug regiments with similar efficacy and safety to current conventional treatments while reducing the treatment time by up to two-thirds. they will allow for more individualized treatment centred on patients. and for the first time in the care of multi-drug resistant tuberculosis, these treatments can be used in nearly all cases of MDR-TB, including in children, adolescents, adults, and pregnant people."

end ID.]

multi-drug resistant tuberculosis (MDR-TB) is a form of tuberculosis that is particularly difficult to treat due to resistance to the 2 most powerful firstline antibiotics. many people are still treated with conventional treatments that are long (up to 24 months), ineffective, and often cause terrible side effects.

every year, there are about 500,000 new cases of MDR-TB worldwide - but only a tiny fraction are successfully treated. the endTB trial, led by MSF (médecins sans frontières/doctors without borders), PIH (partners in health) and IRD (interactive research and development), funded by Unitaid, and featuring 754 participants in 7 countries is a randomized, controlled trial designed to provide high-quality evidence on new, all-oral, shortened drug regimens.

one of the new regimens was found to be even more effective than current conventional treatments. the new trial also added an additional 4th regimen as an alternative for people who can’t tolerate some TB drugs.

there are now — for the first time ever! — 5 all-oral regimens that are effective against MDR-TB in 9 months or less and which are as good or better than a contemporary standard-of-care control. if recommended by WHO, they can be used in nearly all cases of MDR-TB, including children, adolescents, adults, and pregnant people, a first in MDR-TB care. two of the non-inferior regimens cost under $400, and a third costs under $600, for the full course of treatment.

EDIT: press release from endTB for a source

Make your own John Green Vision Board imgflip.com/i/8bddfw via @imgflip

On the occasion of World Tuberculosis Day (March 24), Trust-In Hospital joins the global effort to raise awareness about Tuberculosis (TB), a serious yet preventable and treatable lung infection.

Tuberculosis primarily affects the lungs and spreads through the air when an infected person coughs or sneezes. Early diagnosis and timely treatment are key to preventing complications and stopping its spread.

Let’s work together to: ✔ Promote early screening and diagnosis ✔ Support patients through proper treatment ✔ Spread awareness to eliminate TB

At Trust-In Hospital, we are committed to delivering compassionate care, advanced diagnostics, and effective treatment for respiratory and infectious diseases.

📞 Call us today: +91 8050706071/72

On World Tuberculosis Day, Paradip Port Authority stands united in the fight against TB. Together, through awareness, early detection, and collective action, we can build a healthier and stronger society.

Let us commit to ending TB and ensuring a safer future for all.

Every breath matters. 🌍 On World Tuberculosis Day, let’s unite to eliminate TB and build a healthier tomorrow.

India accounts for over a quarter of global TB cases — awareness, early diagnosis & complete treatment can save millions of lives.

At Nordic Formulations, we stand committed to supporting quality healthcare solutions for a TB-free India.